Melanoma: from surgery to immunotherapy

Join us for an engaging seminar exploring how research advances are improving melanoma care today.

During the seminar you will:

• discover how surgical techniques have developed over time
• learn how the Merlin Assay is improving risk prediction
• explore new insights into the immune response that are driving the next generation of targeted antibody therapies

Our speakers will also explain recent progress in medical treatments and highlight important national clinical trials that are shaping the future of melanoma care.

The seminar ends with a question and answer session, giving you the opportunity to ask questions and hear directly from leading specialists.

Programme

Welcome and introduction, 5:30pm to 5:35pm

Sean Whittaker, Professor of cutaneous oncology, St Johns Institute of Dermatology
King's College London Medical Director for NHSE south east England genomic medicine service
Laboratory hub co-director KHP comprehensive cancer centre

Melanoma research presentations, 5:35pm to 6:40pm

1. Surgical progress, Hawys Lloyd Hughes, consultant plastic surgeon 
2. Merlin Assay to define high and low risk melanoma, Zena Willsmore, consultant dermatologist
3. Studying the immune response in melanoma patients: targeted antibody therapy, Professor Sophia Karagiannis, Professor of translational cancer immunology and immunotherapy
4. Medical management of melanoma 'then and now', Mark Harries, consultant medical oncologist
5. Innovative national clinical trials, Yin Wu, Welcome Trust career development fellow and honorary consultant medical oncologist

Questions and answers, 6:35pm to 7pm

All